Delivery Order SPE2DB24D1205-SPE2DB25FCWHW
Award Date
5/1/25
Potential Completion Date
5/22/25
Potential Value
$9.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award, valued at $9,565.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPZELCA 4 MG VIALS, a specialty medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,131.12, is for the delivery of ZEPZELCA 4 MG VIALS. It is a firm fixed-price delivery order contract with an ultimate completion date of April 29, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,337.72 firm-fixed-price delivery order is for the supply of ZEPZELCA 4 MG VIALS, a specialized pharmaceutical product. The contract has an ultimate completion date of December 31, 2024 and was awarded on December 9, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,565.56, is a Firm Fixed Price Delivery Order for the supply of ZEPZELCA 4 MG VIALS. The contract has an ultimate completion date of April 15, 2025 and was awarded on March 25, 2025. AmerisourceBergen is the prime contractor for this award, and there is no set-aside designation indicated. The contract supports military...
This federal contract award, valued at $9,565.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of ZEPZELCA 4 MG VIALS. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 13, 2025. No set-aside designation was used for this award. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $18,051.52, is for the delivery of the pharmaceutical product Zepzelca 4 mg vials. This is a firm fixed price delivery order contract with a period of performance through September 30, 2024. The contract does not have a set-aside designation. As a major pharmaceutical distributor, AmerisourceBergen has been awarded numerous federal contracts...
This federal contract award, valued at $13,726.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of medical products, including a specific pharmaceutical product, ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a...
This federal contract award with ID SPE2DB22D2007|SPE2DB24FJ2KC was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $9,025.76 firm-fixed-price delivery order is for the pharmaceutical product ZEPZELCA 4 MG VIALS, with a completion date of May 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $8,890.86 firm fixed price contract is for the delivery of ZEPZELCA 4 MG VIALS, a pharmaceutical product, to support DLA Troop Support Medical facilities. The contract has a completion date of January 19, 2024. No set-aside designation was used. AmerisourceBergen Drug Corp, a for-profit organization, is a prime...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order issued under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract covers the delivery of pharmaceutical products, including a medication called ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML. The award has a ceiling value of $1,584.76 and a completion date of September 25, 2024. The contract is a Firm Fixed Price...